The invention relates to a crystal form of dihydropyrimidine derivatives, and provides a pharmaceutical composition containing these crystal compounds or prepared from these compounds, and applications of these compounds in the preparation of the medicaments in preventing, processing, treating or mitigating viral diseases of patient, especially hepatitis b infection or diseases caused by hepatitis b infection.